Perceptive Advisors’s MGC Diagnostics MGCD Stock Holding History
Bought
Maintained
Sold
Other funds holding MGCD
KPF
Perceptive Advisors's MGCD Position: Q4 2017 in Review
Perceptive Advisors sold out of MGC Diagnostics (MGCD) in Q4 2017, closing a stake of 252,327 shares — an estimated $2.26M sold.
Perceptive Advisors first reported a position in MGCD in Q2 2013 and held it in 18 quarters. The position peaked at $2.65M in Q2 2014. 12 funds tracked by Wall St. Rank hold MGCD as of Q4 2017.
- Perceptive Advisors reported no remaining MGC Diagnostics position as of Q4 2017 after selling out during the quarter.
- Perceptive Advisors sold 252,327 MGC Diagnostics shares in Q4 2017, an estimated $2.26M.
- Perceptive Advisors first reported a position in MGC Diagnostics in Q2 2013 and held it in 18 quarters.
- Perceptive Advisors's MGC Diagnostics position peaked at $2.65M in Q2 2014.
- 12 funds tracked by Wall St. Rank held MGC Diagnostics as of Q4 2017.
Based on Perceptive Advisors's 13F filing for Q4 2017, filed 14 Feb 2018.